Global Radiopharmaceuticals Market Trends 2021

1
Global Radiopharmaceuticals Market
2
A study, recently conducted by the strategic
consulting and market research firm, BlueWeave
Consulting, revealed that the Global radiopharmace
uticals Market was worth USD 4.31 Billion in the
year 2020. It is estimated to grow at the CAGR of
6.0, earning revenue of around USD 6.43 Billion
by the end of 2027. Increasing chronic disorders
like cancer and cardiovascular diseases across
the world due to the aging population, unhealthy
food habits contribute to the growth of the
Radiopharmaceuticals Market. The high demand for
nuclear medicines like single-photon emission
computerized tomography (SPECT) and Positron
emission tomography (PET) scans for cancer
diagnosis and increasing patient awareness for
accuracy of this method in the diagnosis led to
the market growth. Growth Drivers High demand
for early diagnosis in the event of cancer and
cardiovascular chronic diseases The demand for
radiopharmaceuticals is growing due to an
increase in cancer cases and the increased use of
medical imaging as a diagnostic technique. The
radiopharmaceuticals market is fueled by a high
demand for nuclear medicines such as SPECT and
PET scans used for diagnosing diseases such as
cancer and other chronic illnesses.
3
Impact of COVID-19 in the industry The ongoing
coronavirus-induced pandemic has affected almost
every industry. This also has had a negative
impact on nuclear medicine development,
production, and supply, as well as the growth of
the radiopharmaceuticals industry. COVID-19 has
caused a lockdown in many countries, resulting in
the closure of all industrial establishments
except those that manufacture essential
commodities. The supply chain for
radiopharmaceuticals and diagnostic kits has also
been disrupted as a result of the pandemic.
Moreover, due to suppliers cost, and
transportation issues, nuclear medicine
manufacturers have been facing problems in
obtaining cold kits used for simplifying
radiopharmaceutical production.  Sample Copy of
the Report _at_https//www.blueweaveconsulting.com/ra
diopharmaceuticals-market-rd/report-sample